Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of Hematology (ASH) 2024 ...
Improvements in financial and operational performance. Nano's focus on operational excellence has delivered strong organic growth and meaningful efficiencies, including 29% organic revenue growth in ...